HSBC Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.55M Buy
97,197
+45,665
+89% +$1.67M ﹤0.01% 1004
2025
Q1
$1.86M Buy
51,532
+4,016
+8% +$145K ﹤0.01% 1141
2024
Q4
$1.97M Buy
47,516
+31,416
+195% +$1.31M ﹤0.01% 1169
2024
Q3
$890K Buy
+16,100
New +$890K ﹤0.01% 1419
2024
Q2
Sell
-17,349
Closed -$810K 2676
2024
Q1
$810K Sell
17,349
-2,114
-11% -$98.7K ﹤0.01% 1515
2023
Q4
$931K Sell
19,463
-7,512
-28% -$359K ﹤0.01% 1420
2023
Q3
$958K Buy
26,975
+2,662
+11% +$94.6K ﹤0.01% 1330
2023
Q2
$1.13M Sell
24,313
-2,699
-10% -$126K ﹤0.01% 1309
2023
Q1
$1.08M Sell
27,012
-45,468
-63% -$1.82M ﹤0.01% 1363
2022
Q4
$3.28M Buy
72,480
+61,631
+568% +$2.79M ﹤0.01% 1184
2022
Q3
$457K Sell
10,849
-2,884
-21% -$121K ﹤0.01% 1809
2022
Q2
$810K Sell
13,733
-935
-6% -$55.1K ﹤0.01% 1685
2022
Q1
$1.07M Buy
14,668
+8,231
+128% +$600K ﹤0.01% 1594
2021
Q4
$547K Sell
6,437
-397
-6% -$33.7K ﹤0.01% 1963
2021
Q3
$611K Sell
6,834
-1,838
-21% -$164K ﹤0.01% 1712
2021
Q2
$833K Buy
8,672
+4,463
+106% +$429K ﹤0.01% 1497
2021
Q1
$480K Sell
4,209
-5,753
-58% -$656K ﹤0.01% 1663
2020
Q4
$1.4M Buy
9,962
+4,699
+89% +$659K ﹤0.01% 1161
2020
Q3
$445K Buy
+5,263
New +$445K ﹤0.01% 1625
2020
Q1
Sell
-25,424
Closed -$1.1M 2415
2019
Q4
$1.1M Sell
25,424
-3,024
-11% -$131K ﹤0.01% 1308
2019
Q3
$1.22M Buy
+28,448
New +$1.22M ﹤0.01% 1318
2018
Q2
Sell
-4,167
Closed -$213K 2019
2018
Q1
$213K Buy
+4,167
New +$213K ﹤0.01% 1832
2017
Q1
Sell
-8,645
Closed -$607K 1992
2016
Q4
$607K Buy
+8,645
New +$607K ﹤0.01% 1280
2015
Q3
Sell
-2,141
Closed -$219K 1762
2015
Q2
$219K Buy
+2,141
New +$219K ﹤0.01% 1552